Clover Corporation Expects Strong FY25 Financial Performance

Clover Corporation Limited ( (AU:CLV) ) has shared an announcement.

Clover Corporation Limited announced an expected outperformance in its unaudited Net Profit After Tax (NPAT) for FY25, surpassing market consensus by approximately 20%. The company’s full-year sales are also anticipated to exceed expectations, driven by a favorable product and customer mix, enhanced performance at Melody Dairies and Ecuador operations, and beneficial currency movements. CEO Peter Davey highlighted the strong contribution from Ecuador as a key factor in the company’s global production footprint, emphasizing the company’s robust balance sheet and continued momentum into FY26.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

More about Clover Corporation Limited

Clover Corporation Limited is an Australian publicly listed company specializing in innovative nutritional ingredients for the global food and infant formula markets. The company has evolved from a research and development focus to forming strategic relationships for technology and product commercialization. Clover’s proprietary microencapsulation technology allows for the incorporation of nutritional oils into various food products, ensuring high standards of purity and performance.

Average Trading Volume: 326,778

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$65.13M

See more insights into CLV stock on TipRanks’ Stock Analysis page.